U.S. markets open in 7 hours
  • S&P Futures

    4,129.75
    -18.00 (-0.43%)
     
  • Dow Futures

    33,848.00
    -114.00 (-0.34%)
     
  • Nasdaq Futures

    12,564.00
    -60.00 (-0.48%)
     
  • Russell 2000 Futures

    1,982.90
    -10.60 (-0.53%)
     
  • Crude Oil

    73.80
    +0.41 (+0.56%)
     
  • Gold

    1,889.20
    +12.60 (+0.67%)
     
  • Silver

    22.51
    +0.11 (+0.49%)
     
  • EUR/USD

    1.0793
    -0.0003 (-0.03%)
     
  • 10-Yr Bond

    3.5320
    0.0000 (0.00%)
     
  • Vix

    18.33
    -0.40 (-2.14%)
     
  • GBP/USD

    1.2061
    +0.0004 (+0.04%)
     
  • USD/JPY

    131.6890
    +0.5390 (+0.41%)
     
  • BTC-USD

    22,839.95
    -544.61 (-2.33%)
     
  • CMC Crypto 200

    524.68
    -12.18 (-2.27%)
     
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • Nikkei 225

    27,693.65
    +184.19 (+0.67%)
     

UK's Regulatory Agency Backs Pfizer/BioNTech's COVID-19 Vaccine For Youngest Kids

  • The Medicines and Healthcare products Regulatory Agency (MHRA) authorized the vaccine - made by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for children aged six months to four years old.

  • This decision was endorsed after it was deemed safe and effective based on an ongoing clinical trial involving 4,526 participants.

  • The vaccine is tailored for use in this age group - it is a lower dose version than the one used in children aged five to 11 years.

  • Related: Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages.

  • It is given as three injections in the upper arm, with the first two doses given three weeks apart, followed by a third dose administered at least two months after the second dose.

  • This presentation is designed for this new age group and given at a lower dose than those used in individuals aged 5 to 11 years (3 micrograms compared with 10 micrograms).

  • The Comirnaty COVID vaccine has met the MHRA's required safety, quality, and effectiveness standards to be authorized for use in this age group.

  • Price Action: PFE shares are down 2.38% at $49.53, and BNTX shares are down 3.96% at $160.10 on the last check Monday.

  • Photo via Wikimedia Commons

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.